US 8491883
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
granted A61KA61K35/12A61P
Quick answer
US patent 8491883 (Treatment of amyotrophic lateral sclerosis using umbilical derived cells) held by Advanced Technologies and Regenerative Medicine, LLC expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Advanced Technologies and Regenerative Medicine, LLC
- Grant date
- Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K35/12, A61P, A61P21/00, A61P21/02